Background: Sarcopenia is a progressive muscle disorder characterized by muscle wasting, decreased strength, and a substantially elevated risk of developing severe and potentially life-threatening health complications. For decades, muscle wasting has been recognized as a clinical symptom in various severe diseases and conditions. However, with increasing life expectancy and an aging population, sarcopenia has emerged as a prominent age-related condition in primary care, significantly contributing to disability and mortality rates. Aim and Objective: Our goal was to elucidate the clinical characteristics associated with sarcopenia prevalence in postmenopausal women with type 1 osteoporosis. Methodology: 370 postmenopausal osteoporosis patients who routinely visited the physiotherapy department at Ali Fatima Hospital were examined in this cross-sectional investigation. Mean age 64.59 ± 5.85 years, it was discovered that the patients' quality of life, postural stability, muscular strength, and balance were related to the existence of sarcopenia. Conclusion: In summary, among postmenopausal female patients with type 1 osteoporosis, the incidence of sarcopenia was relatively high (90.35%), affecting quality of life in 39.82% of patients, postural instability in 92.21% of patients, and balance in 39.92% of patients.

Background: Intimate partner violence (IPV) is one of the most common forms of domestic violence. Research on Intimate Partner Violence (IPV) prevalence using national samples is scarce. This study aims to estimate trends of IPV prevalence by sex and to identify the correlates of IPV among the Mexican population. Methods: We used data from Mexico's 2011 and 2016 National Survey of Addictions (NSA). The analytic sample consists of 44,963 individuals aged 14 to 65 years old. Poisson regression models regressed IPV on substance use behaviors (alcohol and drug use) and sociodemographic factors. Results: Overall, IPV prevalence did not change in the study period (From 15.6% in 2011 to 14.9% in 2016). The associated factors to IPV were having a partner who uses alcohol (APR) =1.68, 95%CI 1.54-1.84), having a partner who uses drugs (APR=2.80, 95%CI 2.46 -3.18). Living in an urban (APR=1.18, 95% CI 1.05-1.33) or metropolitan area (APR=1.16, 95% CI 1.04-1.28) was associated with a higher prevalence of IPV. Single marital status (APR=0.66, 95% CI 0.56-0.78) was associated with a lower prevalence of IPV. Conclusions: The IPV-associated factors are similar in both sexes, so comprehensive prevention and future interventions must consider the two directions of IPV (victim and perpetrator).